Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10070573 | European Journal of Surgical Oncology (EJSO) | 2005 | 17 Pages |
Abstract
TACE has shown to be a valuable therapy with survival benefits in strictly selected patients with unresectable HCC. RFA and PEI are now considered as the local ablative techniques of choice for the treatment of, preferably small, HCC. When tumours are located close to bile ducts or large vessels, PEI remains a valuable therapy. Completeness of ablation can be more easily monitored during cryoablation and another advantage of cryoablation is the possibility of edge freezing. The results of ILC are comparable to RFA with only few side effects and high tumour response rates.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M.C. Jansen, R. van Hillegersberg, R.A.F.M. Chamuleau, O.M. van Delden, D.J. Gouma, T.M. van Gulik,